Cogent Biosciences COGT
NASDAQ COGT
$31.31 -0.12 (-0.38%)
At close: Oct 22, 2026 · 4:00 PM EDT

Cogent Biosciences (COGT) FCF Margin (2017 - 2020)

Updated

Cogent Biosciences' FCF Margin was -455.47% in FY2020, down 270.81 percentage points from -184.66% in FY2019.

Analysis

Cogent Biosciences (COGT) FCF Margin (2017 - 2020) Analysis & Trends

From FY2017 onward, Cogent Biosciences has reported FCF Margin for 4 years.

  • FCF Margin shows a three-year change of -135.53 percentage points (FY2017 to FY2020).
  • Per Business Quant data, FCF Margin in earlier years was -184.66% in FY2019 (+154.75 pp), -339.41% in FY2018 (-19.47 pp) and -319.94% in FY2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Eli Lilly 1,140.21 Bn 1,108.80 Bn 19.71 Bn 33.76%
2 Johnson & Johnson 632.33 Bn 552.19 Bn 17.30 Bn 25.03%
3 AbbVie 500.02 Bn 473.13 Bn 12.70 Bn 18.33%
4 Merck 355.31 Bn 309.69 Bn 12.21 Bn 26.96%
5 Novartis Ag 300.67 Bn 264.66 Bn 11.24 Bn 38.60%
6 Astrazeneca 263.56 Bn 237.25 Bn 12.86 Bn 6.55%
7 Amgen 237.81 Bn 193.20 Bn 7.24 Bn 34.70%
8 Gilead Sciences 194.42 Bn 168.61 Bn 6.22 Bn 44.00%
9 Pfizer 171.28 Bn 117.93 Bn 10.94 Bn 2.01%
10 Cogent Biosciences 5.23 Bn 2.28 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2020 -3,290.71%
Jun 30, 2020 -1,576.52%
Mar 31, 2020 -112.26%
Dec 31, 2019 -55.32%
Sep 30, 2019 -998.53%
Jun 30, 2019 -361.50%
Mar 31, 2019 -378.64%
Dec 31, 2018 -237.06%
Sep 30, 2018 -374.99%
Jun 30, 2018 -498.26%
Mar 31, 2018 -362.88%
Dec 31, 2017 -311.63%
Sep 30, 2017 -281.64%
Jun 30, 2017 -287.54%
Mar 31, 2017 -415.33%
API Access

Cogent Biosciences FCF Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=fcf-margin&ticker=COGT&period=max&api_key=YOUR_API_KEY